Evidence map›Paper›PMID 31806027›Full record

ArticleMalaria journal2019

Changing plasma cytokine, chemokine and growth factor profiles upon differing malaria transmission intensities.

Ruth Aguilar, Joseph J Campo, Silvia Chicuecue, Pau Cisteró, Alba Català, Leopoldina Luis, Itziar Ubillos, Beatriz Galatas, Pedro Aide, Caterina Guinovart and 2 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Ruth AguilarISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain.
Joseph J CampoISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain.
Silvia ChicuecueCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Pau CisteróISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain.
Alba CatalàISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain.
Leopoldina LuisCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Itziar UbillosISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain.
Beatriz GalatasISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain.
Pedro AideCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Caterina GuinovartISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain.
Gemma MoncunillISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain. gemma.moncunill@isglobal.org.ORCID http://orcid.org/0000-0001-5105-9836
Carlota DobañoISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain. carlota.dobano@isglobal.org.
Barcelona Institute for Global Health · ESManhiça Health Research Centre · MZ

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR 2010FI_B 00168Department of Health of the Catalan Government SLT006/17/00109MINECO RYC-2008-02631MINECO SAF2008-00743
6 · The paper itself

Abstract

backgroundMalaria epidemiological and immunological data suggest that parasite tolerance wanes in the absence of continuous exposure to the parasite, potentially enhancing pathogenesis. The expansion of control interventions and elimination campaigns raises the necessity to better understand the host factors leading to susceptibility or tolerance that are affected by rapid changes in malaria transmission intensity (MTI). Mediators of cellular immune responses are responsible for the symptoms and pathological alterations during disease and are expected to change rapidly upon malaria exposure or cessation.

methodsThe plasma concentrations of 30 cytokine, chemokine and growth factors in individuals of all ages from a malaria endemic area of southern Mozambique were compared between 2 years of different MTI: 2010 (lower, n = 234) and 2013 (higher, n = 143). The effect of the year on the correlations between cytokines, chemokines and growth factors and IgGs to Plasmodium falciparum (markers of exposure) was explored. The effects of age, sex, neighbourhood and parasitaemia on analyte levels and their interactions with year were also assessed.

resultsAn inverse correlation of several cellular immune mediators with malarial antibodies in 2013, and a lack of correlation or even a positive correlation in 2010 were observed. Most cytokines, chemokines and growth factors, regardless of their immune function, had higher concentrations in 2010 compared with 2013 in P. falciparum-infected and uninfected subjects. Age and neighbourhood showed an effect on analyte concentrations.

conclusionsThe results show a different regulation of the cellular immune response in 2010 vs 2013 which could be related to a loss of immune-tolerance after a decline in MTI in 2010 and previous years, and a rapid re-establishment of tolerance as a consequence of more continuous exposure as MTI began increasing in 2012. Cellular immune mediators warrant further investigation as possible surrogates of MTI-associated host susceptibility or tolerance.

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkersChildChild, PreschoolCross-Sectional StudiesFemaleHumansImmunity, CellularInfantInfant, NewbornMalaria, FalciparumMaleMiddle AgedBiomarkersAgeAntibodiesChemokinesCytokinesGrowth factorsImmunityMalaria transmission intensityPlasmodium falciparumTolerance

Identifiers

PMID31806027
PMCPMC6896751
OpenAlexW2993531653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.